Source abstract
Abstract
Clinically, significant challenges remain in the treatment of implant-associated osteomyelitis. Herein, we modified the process of an active screen plasma surface technique to prepare a silver nanoparticle coating and then performed in vitro and in vivo experiments to investigate the effectiveness of the silver nanoparticle-coated products prepared using this innovative technique in treating Staphylococcus - and Pseudomonas aeruginosa -induced osteomyelitis. Consequently, the microstructures, antibacterial properties, corrosion performance, biocompatibility, and biosafety of the materials were evaluated in our study. The antibacterial capacity of 2h-Ag-aspsm@SS in vitro was investigated using microbiological counting assays, bacterial viability assays, biofilm formation observations, and the expression of biofilm, compared to antibiotic bone cement nails and control groups. Similarly, the antibacterial capacity of 2h-Ag-aspsm@SS in vivo was investigated through micro-CT, microbiological cultures, and histopathological staining. The biocompatibility and safety examinations, including blood biochemical tests and histology, showed that Ag-aspsm@SS caused no obvious harm to the body. In summary, our study demonstrated that 2h-Ag-aspsm@SS could potentially serve as an implant for treating implant-associated osteomyelitis with a long-lasting antimicrobial capacity.
Source: openalex_inverted_index · Quality: baseline
Affiliations
Department of Orthopaedic Surgery, Shanghai ZhongYe Hospital, Genertec Universal Medical Group, Shanghai 200941, PR China
Department of Orthopaedic Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, PR China
Institute of Phase Transformation and Complex Microstructure, School of Materials Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, PR China
Funding
Shanghai Baoshan Science and Technology Commission · Baoshan District Health Commission Excellent Youth Program